Educational content on VJNeurology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

CONy 2020 | Neurological effects of COVID-19: looking at previous data

Michael Heneka • 5 Nov 2020
CONy 2020
Alzheimer’s Disease

Michael Heneka, MD, University of Bonn, Bonn, Germany, discusses the neurological deficits following COVID-19 infection. Previous data has shown that after the presence of sepsis, there are cases of brain atrophy and cognitive decline. Following COVID-19 infection, there could be similar changes. Currently, the neurological consequences of COVID-19 are being investigated in prospective clinical trials. This interview took place during the Virtual World Congress on Controversies in Neurology (CONy) 2020.

More from Michael Heneka

1:03
Inflammation in Alzheimer’s disease: what we know and what’s to come
Michael Heneka • 5 Nov 2020
1:59
Improving animal models in Alzheimer’s disease research
Michael Heneka • 5 Nov 2020

Related Videos

10:24
Comparing cognitive profiles in multiple sclerosis vs. Alzheimer's disease
Laura Hancock et al. • 22 Mar 2024
5:46
The impact of hypertension on neurovascular function in neurodegenerative diseases
Costantino Iadecola • 6 Feb 2024
3:26
Should endovascular thrombectomy be used in patients with pre-morbid dementia?
Aravind Ganesh • 20 Feb 2024
5:09
Defining the neurovasculome: advances in brain health research
Costantino Iadecola • 6 Feb 2024
The content of VJNeurology is intended for healthcare professionals